139.25
4.80 (3.57%)
| Previous Close | 134.45 |
| Open | 134.48 |
| Volume | 901,968 |
| Avg. Volume (3M) | 533,063 |
| Market Cap | 4,107,025,664 |
| Price / Earnings (TTM) | 63.58 |
| Price / Earnings (Forward) | 53.76 |
| Price / Sales | 2.84 |
| Price / Book | 3.49 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2025 |
| Profit Margin | 7.92% |
| Operating Margin (TTM) | -0.74% |
| Diluted EPS (TTM) | 2.19 |
| Quarterly Revenue Growth (YOY) | 22.70% |
| Quarterly Earnings Growth (YOY) | 138.60% |
| Total Debt/Equity (MRQ) | 5.27% |
| Current Ratio (MRQ) | 9.01 |
| Operating Cash Flow (TTM) | 114.68 M |
| Levered Free Cash Flow (TTM) | 42.41 M |
| Return on Assets (TTM) | 4.40% |
| Return on Equity (TTM) | 10.86% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Inspire Medical Systems, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.00 |
|
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 1.11% |
| % Held by Institutions | 119.04% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 230.00 (UBS, 65.17%) | Buy |
| Median | 150.00 (7.72%) | |
| Low | 97.00 (Leerink Partners, -30.34%) | Hold |
| Average | 151.00 (8.44%) | |
| Total | 7 Buy, 5 Hold | |
| Avg. Price @ Call | 95.25 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Evercore ISI Group | 02 Sep 2025 | 150.00 (7.72%) | Buy | 94.51 |
| Leerink Partners | 15 Aug 2025 | 97.00 (-30.34%) | Hold | 87.77 |
| JP Morgan | 05 Aug 2025 | 110.00 (-21.01%) | Hold | 87.91 |
| Lake Street | 05 Aug 2025 | 150.00 (7.72%) | Buy | 87.91 |
| Piper Sandler | 05 Aug 2025 | 150.00 (7.72%) | Buy | 87.91 |
| RBC Capital | 05 Aug 2025 | 180.00 (29.26%) | Buy | 87.91 |
| Stifel | 05 Aug 2025 | 140.00 (0.54%) | Hold | 87.91 |
| Truist Securities | 05 Aug 2025 | 125.00 (-10.23%) | Hold | 87.91 |
| UBS | 05 Aug 2025 | 230.00 (65.17%) | Buy | 87.91 |
| Wells Fargo | 05 Aug 2025 | 101.00 (-27.47%) | Hold | 87.91 |
| Keybanc | 22 Jul 2025 | 197.00 (41.47%) | Buy | 129.43 |
| Morgan Stanley | 15 Jul 2025 | 182.00 (30.70%) | Buy | 128.00 |
| Show more | ||||
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 26 Aug 2025 | Announcement | Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer |
| 20 Aug 2025 | Announcement | Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference |
| 11 Aug 2025 | Announcement | Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program |
| 04 Aug 2025 | Announcement | Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook |
| 07 Jul 2025 | Announcement | Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |